The prognostic value of neuromedin U in patients with hepatocellular carcinoma
Abstract Background Neuromedin U (NMU) is a neuropeptide belonging to the neuromedin family. Recently, significant associations between NMU and several cancers have been reported. However, no studies have examined the association between NMU and hepatocellular carcinoma (HCC). The purpose of this st...
Main Authors: | Qiao Li, Lingyu Han, Shengnan Ruan, Shunli Shen, Qinghua Cao, Xiuqin Cai, Yuan Yan, Baogang Peng, Yunpeng Hua |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-020-6532-1 |
Similar Items
-
Cocaine-Evoked Locomotor Activity Negatively Correlates With the Expression of Neuromedin U Receptor 2 in the Nucleus Accumbens
by: James M. Kasper, et al.
Published: (2018-11-01) -
Neuromedin U: A Small Peptide in the Big World of Cancer
by: Patrycja Przygodzka, et al.
Published: (2019-09-01) -
Neuromedin U and neurotensin may promote the development of the tumour microenvironment in neuroblastoma
by: Daheng Yang, et al.
Published: (2021-06-01) -
Neuromedins NMU and NMS: An Updated Overview of Their Functions
by: Ludwik K. Malendowicz, et al.
Published: (2021-07-01) -
Effects of sex steroid hormones on neuromedin S and neuromedin U2 receptor expression following experimental traumatic brain injury
by: Mohammad Khaksari, et al.
Published: (2016-10-01)